Centene Corporation (CNC)

CNC · Health Care · United States

Centene Corporation (CNC) is a company in the Health Care sector, based in United States. The stock is held in 24 ETFs we track – with its largest weight of 0.53 % in XUHL (msci-usa-health-care). Anyone holding one of these ETFs also owns a small indirect stake in Centene Corporation.

Very high ETF coverage: 24 of the 95 ETFs we cover hold Centene Corporation, spread across 12 indices. That puts the stock in more ETFs than 92.0 % of the 4,334 stocks we cover.

Held in24 ETFs

Highest weight0.53 %

Indices12

SectorHealth Care

CountryUnited States

ISINUS15135B1017

WKN766458

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date	+60.4 %	1 year	+107.6 %
1 month	+2.5 %	3 months	+8.9 %
Calendar year 2025	-32.1 %

52W

Data note 3

Measured in euros, Centene Corporation returned +63.4 % year to date and +112.4 % over one year. The gap to the dollar figures above comes from the exchange rate alone: each daily price is converted at the ECB euro reference rate for the same day.

Data note 4

Risk metrics

Max drawdown-68.6 %

Volatility p.a.51.4 %

Data note 5

Below peak-17.7 %

Beta to S&P 5000.35

Correlation to S&P 5000.10

The close on Sep 16, 2026 was 17.7 % below the highest close since Aug 12, 2024, reached on Sep 3, 2024. Over the last 252 trading days, on days when the S&P 500 rose or fell 1 %, Centene Corporation moved on average 0.35 % in the same direction. The correlation of 0.10 shows how reliable that average is: the broad market explained only a small share of the daily moves.

Data note 6

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Correlated with
Instrument	r	−1 … +1
Elevance Health Inc.	+0.73
Humana Inc.	+0.64
UnitedHealth Group Incorporated	+0.62
Cigna Group	+0.48
CVS Health Corporation	+0.44
NFP	+0.39
CFG	-0.32
PLUME	-0.26
ONDO	-0.25

Data note 7

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.

Revenue174.6 bn $

Net income-6.7 bn $

Diluted EPS-13.53 $

Net margin-3.8 %

Gross margin8.1 %

Return on equity-33.4 %

Equity ratio26.0 %

Revenue growth+20.0 %

Revenue and profit by fiscal year
Fiscal year	Revenue	Net income	Margin
FY2023	140.1	2.7	1.9 %
FY2024	145.5	3.3	2.3 %
FY2025	174.6	-6.7	-3.8 %

Data note 8

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
XUHL / XUHC	msci-usa-health-care	0.53 %	€5.30
XDWH	msci-world-health-care	0.39 %	€3.90
SPFS	msci-world-health-care	0.39 %	€3.90
XDEV	msci-world-value	0.22 %	€2.20
2B7K	msci-world-sri	0.15 %	€1.50
WVAL	msci-world-value	0.12 %	€1.20
XDEB	msci-world-minimum-volatility	0.11 %	€1.10
XDEM	msci-world-momentum	0.07 %	€0.70
SPYL / SPY5	sp500	0.05 %	€0.50
SXR8	sp500	0.05 %	€0.50
XD9U / XD9D	msci-usa	0.05 %	€0.50
EUNL	msci-world	0.04 %	€0.40
IUSQ	msci-acwi	0.04 %	€0.40
XDWD / XDWL	msci-world	0.04 %	€0.40
SWWD	msci-world	0.03 %	€0.30
WIMI	msci-world-imi	0.03 %	€0.30
SPYI / SPSA	msci-acwi-imi	0.03 %	€0.30
SPYY	msci-acwi	0.03 %	€0.30
SPPW	msci-world	0.03 %	€0.30

Data note 9

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Centene Corporation as of the fund's latest holdings list.

Weight in EUNL since 2019

Sep 30, 2019Sep 16, 2026

In EUNL, a fund tracking the MSCI World, Centene Corporation had a weight of 0.04 % on Sep 30, 2019 and 0.04 % on Sep 16, 2026. Its share peaked at 0.10 % on Mar 31, 2020. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 10

How much Centene Corporation overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Centene Corporation — the figure counts the ETFs holding both.

Data note 11

Key figures side by side

Key figures compared with stocks of similar ETF exposure
Stock	1 year	Volatility p.a.	Net margin	Revenue growth
Centene Corporation	+107.6 %	51.4 %	-3.8 %	+20.0 %
Cigna Group	-4.7 %	30.7 %	2.2 %	+11.2 %
Elevance Health	+33.1 %	35.3 %	2.8 %	+12.5 %
Biogen	+50.3 %	32.2 %	13.1 %	+2.2 %
Quest Diagnostics Incorporated	+37.1 %	23.0 %	9.0 %	+11.8 %
Cooper Companies	-16.2 %	33.6 %	9.2 %	+5.1 %
Zimmer Biomet Holdings	-2.4 %	29.6 %	8.6 %	+7.2 %
Incyte Corporation	+48.7 %	34.3 %	25.0 %	+21.2 %
CVS Health Corporation	+24.8 %	34.0 %	0.4 %	+7.8 %

Return and volatility from our daily closing prices in US dollars; margin and growth from the latest SEC annual filing. Fiscal years do not all end on the same date.